Language Settings
Select Website Language
newshunt
newshunt

Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

1 day ago

The United States plans significant tariffs on imported generic medicines. These duties will rise to 200% in the coming years. Dr Reddy's Laboratories anticipates higher medicine prices for American consumers. Shifting manufacturing to the US is currently considered impractical by the company. India faces substantial exposure as a major generic medicine exporter to the US.
Click here to Read More
Previous Article
'Aam'ezing voyage: UP's mangoes make first sea journey to Dubai
Next Article
US stock market today: Wall Street drifts in mixed trading; oil prices rise another 3%

Related Business Updates:

Are you sure? You want to delete this comment..! Remove Cancel

Comments (0)

    Leave a comment